SCHEMBL23261815

SCHEMBL23261815

CCC(C)(C)N1CCCCC1(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16232096 0.79
SCHEMBL15497006 0.76
SCHEMBL21555139 0.64
SCHEMBL21555141 0.64
SCHEMBL178517 0.63 CYP2B6 (0.33)
SCHEMBL22260679 0.63
SCHEMBL22778619 0.62 SOS1 (0.40)
SCHEMBL9925976 0.61 CYP2B6 (0.37)
SCHEMBL11587102 0.61 CYP2B6 (0.37)
SCHEMBL90401 0.61

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11560366-B2 Bicyclo[1.1.1]pentane inhibitors of dual leucine zipper (DLK) kinase for the treatment of disease BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) 2023-01-24 US disclosed
US-20210115010-A1 BICYCLO[1.1.1]PENTANE INHIBITORS OF DUAL LEUCINE ZIPPER (DLK) KINASE FOR THE TREATMENT OF DISEASE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM 2021-04-22 US disclosed